Understand the significant growth trajectory of the Handheld ECG Devices segment, which is expected to reach US$1.9 Billion by 2030 with a CAGR of a ...

Together, these factors underscore the transformative potential of mobile ECG devices in addressing global healthcare challenges. Modality (Handheld ECG Devices, Band ECG Devices, Pen ECG Devices ...

Together, these factors underscore the transformative potential of mobile ECG devices in addressing global healthcare challenges. Modality (Handheld ECG Devices, Band ECG Devices, Pen ECG Devices, ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

IIT Delhi released its Research Impact Report on the occasion of its 67th Foundation Day on Monday The report talks about the Institute contribution to nat ...

By taking action with your doctor, they can properly diagnosis health issues, and help develop an action plan for your life.